Stocks and Investing Stocks and Investing
Wed, August 14, 2024
Tue, August 13, 2024

Matthew Harrison Upgraded (AVIR) to Hold and Increased Target to $6.88 on, Aug 13th, 2024


Published on 2024-10-28 13:37:19 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Upgraded "Atea Pharmaceuticals, Inc." (AVIR) to Hold and Increased Target from $2 to $6.88 on, Aug 13th, 2024.

Matthew, nor any peers, have made any analyst calls on AVIR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30